ArticleJournal of hematology & oncology2020

CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110.

Juan Manuel Domínguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.